In this week’s View, Dr. Eagle looks at exercise training in patients with hypertrophic cardiomyopathy (HCM). He then reviews the diagnosis and management of Kawasaki Disease. Finally, Dr. Eagle ...

Disparities in health care disproportionally impact under-resourced and minority communities resulting in excess mortality and morbidity. Decreasing and eliminating these disparities will improve ...

Edoxaban was comparable to warfarin in preventing stroke or systemic embolism and intracardiac thrombus in patients with non-valvular atrial fibrillation (AFib) within three months after bioprosthetic ...

Norland K, Schaid DJ, Naderian M, Na J, Kullo IJ.

Keywords: American Heart Association, AHA Annual Scientific Sessions, AHA24Slides, Visual Abstract ...

The U.S. Food and Drug Administration (FDA) posted a letter to health care providers on Nov. 15, announcing that Getinge/Maquet has issued an Urgent Medical Device Removal notice warning against use ...

Three dual combinations of hypertension medications in one polypill – amlodipine and perindopril; perindopril and indapamide; or amlodipine and indapamide – were equally effective in reducing blood ...

Sudden cardiac death (SCD) in obesity is the focus of a JACC: State-of-the-Art review of the mechanisms as well as current evidence for its management, gaps in knowledge and future research, published ...

Zerlasiran, a short-interfering RNA, was well-tolerated and reduced time-averaged lipoprotein(a) [Lp(a)] concentration by more than 80% during 36 weeks of treatment in patients with atherosclerotic ...

The 2024 multisociety Guideline for the Management of Lower Extremity Peripheral Artery Disease (PAD) highlights the implementation of the PAD National Action Plan as a critical advocacy priority, ...

American Society of Echocardiography (ASE) guidelines for echocardiographic evaluation of aortic regurgitation (AR) were found to “display very good performance” in detecting significant AR, according ...

Among patients at high risk of stroke or systemic embolism, the AMPLATZER Amulet left atrial appendage (LAA) occluder was as safe and effective as the Watchman 2.5 device at five-year follow-up, ...